Adrenochrome Explained

Adrenochrome is a chemical compound produced by the oxidation of adrenaline (epinephrine). It was the subject of limited research from the 1950s through to the 1970s as a potential cause of schizophrenia. While it has no current medical application, the semicarbazide derivative, carbazochrome, is a hemostatic medication.

Despite this compound's name, it is unrelated to the element chromium; instead, the ‑chrome suffix indicates a relationship to color, as pure adrenochrome has a deep violet coloration.

Chemistry

The oxidation reaction that converts adrenaline into adrenochrome occurs both in vivo and in vitro. Silver oxide (Ag2O) was among the first reagents employed for this,[1] but a variety of other oxidising agents have been used successfully.[2] In solution, adrenochrome is pink and further oxidation of the compound causes it to polymerize into brown or black melanin compounds.[3]

History

Several small-scale studies (involving 15 or fewer test subjects) conducted in the 1950s and 1960s reported that adrenochrome triggered psychotic reactions such as thought disorder and derealization.[4]

In 1954, researchers Abram Hoffer and Humphry Osmond claimed that adrenochrome is a neurotoxic, psychotomimetic substance and may play a role in schizophrenia and other mental illnesses.[5]

In what Hoffer called the "adrenochrome hypothesis",[6] he and Osmond in 1967 speculated that megadoses of vitamin C and niacin could cure schizophrenia by reducing brain adrenochrome.[7] [8]

The treatment of schizophrenia with such potent anti-oxidants is highly contested. In 1973, the American Psychiatric Association reported methodological flaws in Hoffer's work on niacin as a schizophrenia treatment and referred to follow-up studies that did not confirm any benefits of the treatment.[9] Multiple additional studies in the United States,[10] Canada,[11] and Australia[12] similarly failed to find benefits of megavitamin therapy to treat schizophrenia.

The adrenochrome theory of schizophrenia waned, despite some evidence that it may be psychotomimetic, as adrenochrome was not detectable in people with schizophrenia.

In the early 2000s, interest was renewed by the discovery that adrenochrome may be produced normally as an intermediate in the formation of neuromelanin. This finding may be significant because adrenochrome is detoxified at least partially by glutathione-S-transferase. Some studies have found genetic defects in the gene for this enzyme.[13]

Adrenochrome is also believed to have cardiotoxic properties.[14] [15]

In popular culture

External links

Notes and References

  1. Veer . W. L. C. . Melanin and its precursors II. On adrenochrome . Recueil des Travaux Chimiques des Pays-Bas . 1942 . 61 . 9 . 638–646 . 10.1002/recl.19420610904.
  2. Heacock . R. A. . The Chemistry Of Adrenochrome And Related Compounds . Chemical Reviews . 1 April 1959 . 59 . 2 . 181–237 . 10.1021/cr50026a001 .
  3. Book: A. Hoffer. H. Osmond. The Hallucinogens. 22 October 2013. Elsevier. 978-1-4832-6169-0. 272–273.
  4. Smythies . John . John Raymond Smythies . 37594882 . The adrenochrome hypothesis of schizophrenia revisited . . 4 . 2 . 147–150 . January 2002 . 12829415 . 10.1080/10298420290015827 . 10.1.1.688.3796 . 1029-8428 . 1476-3524 . 50166444 .
  5. Hoffer . Abram . Abram Hoffer . Osmond . Humphrey . Humphry Osmond . John . Smythies. John Raymond Smythies . Schizophrenia: A New Approach. II. Result of a Year's Research . . 100 . 418 . 29–45 . January 1954 . 13152519 . 10.1192/bjp.100.418.29 . 1472-1465 . 0007-1250 . 89649366 . 1537306 . 42531852 . dmy-all .
  6. Hoffer . Abram . Abram Hoffer . Osmond . Humphrey . Humphry Osmond . The Adrenochrome Hypothesis and Psychiatry . 2024-03-15 . . 14 . 1 . First Quarter 1999 . 49–62 . https://web.archive.org/web/20240220043758/http://www.orthomolecular.org/library/jom/1999/articles/1999-v14n01-p049.shtml . 2024-02-20 . live . 0834-4825 . 15726974 . 41468628 . dmy-all.
  7. Book: Hoffer . Abram . Abram Hoffer . Osmond . Humphrey . Humphry Osmond . 1968-01-01 . The Hallucinogens . registration . en . First . . 978-0123518507 . 66030086 . 332437 . OL35255701M . 2024-03-15 . . dmy-all.
  8. Hoffer A . 1994 . Schizophrenia: An Evolutionary Defense Against Severe Stress . Journal of Orthomolecular Medicine . 9 . 4 . 205–2221 .
  9. Web site: Lipton MA, Ban TA, Kane FJ, Levine J, Mosher LR, Wittenborn R . Task Force Report on Megavitamin and Orthomolecular Therapy in Psychiatry . American Psychiatric Association . 1973 . 7 September 2020 . 23 February 2021 . https://web.archive.org/web/20210223194022/https://www.old.quackwatch.org/01QuackeryRelatedTopics/apa_megavitamin.pdf . dead .
  10. 10.1001/archpsyc.1973.01750330010002 . Wittenborn JR, Weber ES, Brown M . Niacin in the Long-Term Treatment of Schizophrenia . Archives of General Psychiatry . 1973 . 28 . 3 . 308–315 . 4569673 .
  11. Ban TA, Lehmann HE . Nicotinic Acid in the Treatment of Schizophrenia: A Summary Report . Schizophrenia Bulletin . 1970 . 1 . 3 . 5–7 . 10.1093/schbul/1.3.5 . free .
  12. Vaughan K, McConaghy N . 38857700 . Megavitamin and dietary treatment in schizophrenia: a randomised, controlled trial . Australian and New Zealand Journal of Psychiatry . 1999 . 33 . 1 . 84–88 . 10197889 . 10.1046/j.1440-1614.1999.00527.x.
  13. Book: Smythies J . Smythies J . Disorders of Synaptic Plasticity and Schizophrenia . 2004 . Elsevier Academic Press . 978-0-12-366860-8 . xv . 1st.
  14. Bindoli . Alberto . Rigobello . Maria Pia . Galzigna . Lauro . Toxicity of aminochromes . Toxicology Letters . July 1989 . 48 . 1 . 3–20 . 10.1016/0378-4274(89)90180-X. 2665188 . 11577/2475305 . free .
  15. Behonick . George S. . Novak . Mark J. . Nealley . Eric W. . Baskin . Steven I. . Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes) . Journal of Applied Toxicology . December 2001 . 21 . S1 . S15–S22 . 10.1002/jat.793. 11920915 . 27865845 .
  16. Friedberg . Brian . The Dark Virality of a Hollywood Blood-Harvesting Conspiracy . Wired . 21 February 2021.
  17. News: Adams . Josie . The truth about adrenochrome . 28 June 2020 . The Spinoff . 7 April 2020.
  18. Web site: Fear and adrenochrome. 4 May 2020. Spectator USA. en-US. 23 May 2020. 20 September 2020. https://web.archive.org/web/20200920020254/https://spectator.us/fear-adrenochrome-conspiracy-theory-drug/. dead.
  19. Web site: How Facebook connects 'pizzagate' conspiracy theorists. NBC News. February 2019 . en. 23 May 2020.
  20. Kantrowitz . Lia . QAnon, Blood Libel, and the Satanic Panic . The New Republic . 8 May 2021 . 29 September 2020.
  21. Friedberg . Brian . The Dark Virality of a Hollywood Blood-Harvesting Conspiracy . February 16, 2022. Wired. July 31, 2020.
  22. News: Hitt. Tarpley. How QAnon Became Obsessed With 'Adrenochrome,' an Imaginary Drug Hollywood Is 'Harvesting' from Kids . The Daily Beast . 27 January 2021 . August 14, 2020.
  23. News: January 21, 2021. QAnon: A Glossary . Anti-Defamation League. February 15, 2022.
  24. Web site: Untangling the Medical Misinformation Around Adrenochrome. Walker-Journey, Jennifer. HowStuffWorks. en-US. live. April 14, 2021. October 25, 2022. April 14, 2021. https://web.archive.org/web/20210414211128/https://science.howstuffworks.com/adrenochrome.htm.
  25. Synthesis of dl-Adrenalin-β-C14 and dl-Adrenochrome-β-C14. ACS Publications. Schayer, Richard W.. Journal of the American Chemical Society . en-US. live. 1952. 74 . 9 . 2441 . 10.1021/ja01129a531 . October 25, 2022. October 25, 2022. https://archive.today/20221025141335/https://pubs.acs.org/doi/10.1021/ja01129a531.
  26. Web site: Method of synthesizing adrenochrome monoaminoguanidine. Google Patents. en-US. live. 1965. October 25, 2022. October 16, 2021. https://web.archive.org/web/20211016150832/https://patents.google.com/patent/US3445478A/en.